Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00375219
What this trial is testing

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 103
Early research (Phase 1)Study completedNCT02556892
What this trial is testing

Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphocytic Leukemia
Janssen Pharmaceutical K.K. 8
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04370457
What this trial is testing

MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMyelodysplastic Syndromes
Centre for Research and Technology Hellas 300
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Not applicableStudy completedNCT03885830
What this trial is testing

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Who this might be right for
CML, Chronic PhaseCML (Chronic Myelogenous LeukemiaCML - Philadelphia Chromosome+2 more
UNC Lineberger Comprehensive Cancer Center 45
Not applicableNot Yet RecruitingNCT07741695
What this trial is testing

Targeting IRAK4 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
IRCCS San Raffaele 50
Large-scale testing (Phase 3)WithdrawnNCT00551239
What this trial is testing

Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

Who this might be right for
LeukemiaLymphoma
CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)UnknownNCT03226301
What this trial is testing

A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations

Who this might be right for
Chronic Lymphocytic Leukemia in RelapseChronic Lymphocytic Leukemia in Remission
Stichting Hemato-Oncologie voor Volwassenen Nederland 230
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Not applicableStudy completedNCT00126477
What this trial is testing

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 750
Testing effectiveness (Phase 2)Study completedNCT00006475
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Who this might be right for
Leukemia
Novartis
Not applicableStudy completedNCT02977312
What this trial is testing

Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Hikma Pharmaceuticals LLC 91
Not applicableLooking for participantsNCT04028531
What this trial is testing

Understanding Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute 2,750
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Ended earlyNCT01612988
What this trial is testing

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia (B-CLL)
French Innovative Leukemia Organisation 74
Testing effectiveness (Phase 2)Study completedNCT00481091
What this trial is testing

ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie 60
Next Page